about
Neuropeptides function in a homeostatic manner to modulate excitation-inhibition imbalance in C. elegansDeveloping novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy modelsA role for galanin N-terminal fragment (1-15) in anxiety- and depression-related behaviors in rats.The G protein-coupled receptor GALR2 promotes angiogenesis in head and neck cancer.Effects of galanin on monoaminergic systems and HPA axis: Potential mechanisms underlying the effects of galanin on addiction- and stress-related behaviorsSingle cell transcriptomics of hypothalamic warm sensitive neurons that control core body temperature and fever response Signaling asymmetry and an extension of chemical neuroanatomy.Susceptibility to chronic pain following nerve injury is genetically affected by CACNG2.The G protein-coupled receptor P2Y14 influences insulin release and smooth muscle function in mice.Identification of the major HHV-6 antigen recognized by cerebrospinal fluid IgG in multiple sclerosis.Gender-specific association of galanin polymorphisms with HPA-axis dysregulation, symptom severity, and antidepressant treatment response.Comprehensive genomic characterization of cutaneous malignant melanoma cell lines derived from metastatic lesions by whole-exome sequencing and SNP array profilingAnalgesic properties of a peripherally acting and GalR2 receptor-preferring galanin analog in inflammatory, neuropathic, and acute pain models.Development of a high-throughput screening-compatible cell-based functional assay to identify small molecule probes of the galanin 3 receptor (GalR3).Dopamine-galanin receptor heteromers modulate cholinergic neurotransmission in the rat ventral hippocampus.Encapsulated galanin-producing cells attenuate focal epileptic seizures in the hippocampus.A 72-hour high fat diet increases transcript levels of the neuropeptide galanin in the dorsal hippocampus of the rat.Homology modeling, docking, and molecular dynamics simulation of the receptor GALR2 and its interactions with galanin and a positive allosteric modulator.Galanin receptors and ligands.Distinct features of neurotransmitter systems in the human brain with focus on the galanin system in locus coeruleus and dorsal raphe.Gene and protein patterns of potential prion-related markers in the central nervous system of clinical and preclinical infected sheepRegulation of neurological and neuropsychiatric phenotypes by locus coeruleus-derived galanin.Bidirectional regulation of stress responses by galanin in mice: involvement of galanin receptor subtype 1Galanin receptor subtypes 1 and 2 as therapeutic targets in head and neck squamous cell carcinoma.Involvement of galanin and galanin receptor 2 in nociceptive modulation in anterior cingulate cortex of normal rats and rats with mononeuropathy.Galanin-like peptide: a key player in the homeostatic regulation of feeding and energy metabolism?Anticonvulsant neuropeptides as drug leads for neurological diseases.Central and peripheral peptides regulating eating behaviour and energy homeostasis in anorexia nervosa and bulimia nervosa: a literature review.GalR3 activation promotes adult neural stem cell survival in response to a diabetic milieu.Novel therapeutic uses and formulations of botulinum neurotoxins: a patent review (2012 - 2014).Novel anti-tumor mechanism of galanin receptor type 2 in head and neck squamous cell carcinoma cells.Rap1 mediates galanin receptor 2-induced proliferation and survival in squamous cell carcinomaSubarachnoid transplantation of immortalized galanin-overexpressing astrocytes attenuates chronic neuropathic pain.Engineering galanin analogues that discriminate between GalR1 and GalR2 receptor subtypes and exhibit anticonvulsant activity following systemic delivery.On the existence and function of galanin receptor heteromers in the central nervous systemTheoretical characterization of galanin receptor type 3 (Gal3 ) and its interaction with agonist (GALANIN) and antagonists (SNAP 37889 and SNAP 398299): an in silico analysis.Galanin in the amniotic fluid and neonatal birth weight: a prospective observational study.Central administration of galanin N-terminal fragment 1-15 decreases the voluntary alcohol intake in rats.Organization of the histaminergic system in adult zebrafish (Danio rerio) brain: neuron number, location, and cotransmitters.The novel anticonvulsant neuropeptide and galanin analogue, NAX-5055, does not alter energy and amino acid metabolism in cultured brain cells.Galanin (1-15) enhances the antidepressant effects of the 5-HT1A receptor agonist 8-OH-DPAT: involvement of the raphe-hippocampal 5-HT neuron system.
P2860
Q27322953-6426F6C3-6CF6-468B-A7C7-DB4F1FF7D400Q28239742-C5507506-AD71-4554-B178-2C4ECDD9A87BQ30627955-1C7E1E85-54D6-46D5-920E-91351363C76CQ33623170-8F68215C-09CF-4A2C-99A9-2C3D05605686Q33643281-504CD2B5-E6FD-4718-BEBE-C61E54B56F8DQ33726456-656F5E0F-8DD9-40C4-80DA-3F60BFE323F3Q34085118-462F575C-4F53-4C9A-8270-D3715E0C8995Q34141128-2F0D23E9-F245-4156-9C85-6B14FB76EB7BQ34414788-70B1D407-6886-4364-AD86-9BC9957C374CQ34661003-AE7546C9-ABA9-4BBB-9B79-D13FE09FB446Q34737562-AC14D2B1-560E-48E7-8565-68ED21A817B4Q34785603-EE05379C-1DE8-4F61-8F57-EB7E1DDA81D5Q35015329-A9F9089F-04E6-4EDB-B2AA-E35608353BF2Q35030514-E75DB001-5E0B-4383-BFDE-42AD74CE9C23Q35045578-6F7B1C77-3484-4D2C-8CE4-504C641DE83AQ35741908-769A2FFB-54B4-417D-841E-EB1B8BE88FA3Q35972120-D7EDE3CA-030F-405A-933E-5FC36E41D86BQ36451712-7974D304-2B4C-413B-B571-471B346879A4Q36598124-92CB09FC-110B-4616-9E92-EA2B3020D078Q36716041-FCAD9929-B7C0-476C-A976-F0CC2AB857DAQ36922331-41C92AB8-0C0A-4415-BC33-02B53F28192BQ37169626-7AD9E8BC-2AB5-45C7-BB48-362E932AD6A2Q37690752-D97DF6BE-45B9-4A3B-8D45-17D541440D8DQ37738001-87F79266-5CED-4EEC-9F64-2729E628DEBEQ37799529-595B4002-D788-43E6-AC3E-9A97AB96E521Q37845684-0AF61604-7E83-405F-A9B5-FC95A58BE32AQ38221334-38250FE2-B5D1-4CAC-928E-02417587C811Q38313561-E69DF78D-0995-4463-B59F-8A920C7B0B7BQ38406085-73E1AFDC-D43B-425D-B30D-4582B6002BFEQ39069156-D95A2F34-1EF2-482D-815D-A80BD9897601Q39587210-D4ADDEE3-F963-4E63-ACBF-12CAA6E5D9B3Q39764492-2A8CEC38-DCAF-4A91-AE1B-C2EF87813B9CQ39830106-D36AB0E8-52DC-4926-8A44-4DFD99BB914FQ41889343-695BEAF7-87F7-4728-BD08-B1122A90AB3DQ45745219-DF5CFBE8-9212-42C1-89A8-6ECB92279053Q47249171-A415DF16-1075-4C49-937D-0BA24F92BB8BQ47567119-722E8A65-C374-4A83-B59F-14170E8128B8Q47994268-CE1909E3-2BFC-4AEF-9CBD-D32CB00AB968Q48041787-6DB40E78-1D05-4969-9EFC-46732983331EQ48065901-57BFA6A1-FA5F-47E5-8C4B-04AE1D925C94
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Galanin, galanin receptors and drug targets
@ast
Galanin, galanin receptors and drug targets
@en
Galanin, galanin receptors and drug targets
@nl
type
label
Galanin, galanin receptors and drug targets
@ast
Galanin, galanin receptors and drug targets
@en
Galanin, galanin receptors and drug targets
@nl
prefLabel
Galanin, galanin receptors and drug targets
@ast
Galanin, galanin receptors and drug targets
@en
Galanin, galanin receptors and drug targets
@nl
P2093
P1476
Galanin, galanin receptors and drug targets
@en
P2093
P2888
P304
P356
10.1007/S00018-008-8153-8
P407
P577
2008-06-01T00:00:00Z